Short-Term ART group (30 months) | p valuea | Short-term ART group (42 months) | p valueb | p valuec | Long-term ART group | |
---|---|---|---|---|---|---|
CpG methylation Index | 0 (0–58.4) | 0.005 | 74.7 (0–85.3) | 0.273 | 0.025 | 77.9 (70.8–86.7) |
Additional CpG methylation Indexd | 0.8 (0–21.0) | 0.155 | 27.0 (4.3–45.1) | 0.163 | 0.074 | 20.0 (13.8–20.0) |
Non–CpG methylation Indexe | 1.3 (0–9.5) | 0.388 | 0 (0–0) | 0.332 | 0.093 | 0 (0–2.2) |
Residual pVL (RNA copies/mL) | 1.4 (0–3.6) | 0.737 | 3.4 (0–7.1) | 0.305 | 0.176 | 0.4 (0–2.9) |
Proviral load (DNA copies/million CD4+ T cells) | 14146 (517–29277) | 0.526 | 3638 (228–10216) | 0.260 | 0.005 | 9780 (4 057–13716) |
Naive CD4+ T cells (%) | 25.2 (20.6–52.6) | 0.944 | 29.1 (18.3–49.1) | 0.888 | 0.114 | 39.4 (11.2–45.4) |
Memory CD4+ T cells (%) | 74.8 (47.4–79.4) | 0.944 | 70.9 (50.9–81.7) | 0.888 | 0.114 | 60.6 (54.6–88.8) |
TSCM (%) | 5.6 (3.0–6.9) | 0.049 | 4.2 (2.9–7.1) | 0.035 | 0.508 | 9.4 (5.7–15.9) |
TCM (%) | 23.2 (15.3–31.2) | 0.673 | 21.7 (12.7–33.0) | 0.439 | 0.169 | 23.8 (19.5–40.9) |
TEM (%) | 12.5 (2.1–20.4) | 0.398 | 10.1 (3.2–12.5) | 0.205 | 0.333 | 6.3 (4.8–9.3) |
TTM (%) | 15.0 (11.3–25.4) | 0.091 | 13.8 (11.4–31.5) | 0.049 | 0.799 | 8.3 (4.5–16.6) |
TNEW (%) | 1.1 (0.6–1.5) | 0.003 | 2.5 (1.6–3.6) | 0.526 | 0.005 | 2.0 (1.5–3.9) |
TTE (%) | 2.3 (0.3–11.1) | 0.181 | 5.0 (1.2–9.8) | 0.944 | 0.285 | 4.8 (2.7–7.8) |